Physician profile
Joanne Arnold
NPI 1487957338
$3,895.72
in general payments reported to CMS, 2019-2025
23 companies · $353 in 2025
The $353 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,571 · 2022: $559 · 2023: $992 · 2024: $422 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,766.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $1,065.51 | 2021-2025 | Omnipod |
| Mannkind Corporation | $899.73 | 2021-2023 | V-Go |
| Sanofi-Aventis U.S. LLC | $579.66 | 2021-2022 | |
| Janssen Biotech, INC. | $256.43 | 2023-2025 | Carvykti, Rybrevant, Tecvayli |
| Astrazeneca Pharmaceuticals LP | $218.17 | 2023-2025 | Enhertu |
| Lilly USA, LLC | $163.03 | 2021-2024 | Mounjaro |
| Rigel Pharmaceuticals, INC. | $119.71 | 2022 | |
| Eisai INC. | $105.47 | 2023 | |
| Gilead Sciences, INC. | $84.07 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.78 | 2021 | |
| Radius Health, INC. | $60.86 | 2021 | |
| Amgen INC. | $41.26 | 2021 | |
| Abbvie INC. | $41.02 | 2021 | |
| Amneal Pharmaceuticals LLC | $21.54 | 2021 | |
| Horizon Therapeutics Plc | $21.53 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $21.47 | 2021 | |
| Alfasigma USA, INC. | $18.85 | 2021 | |
| Clarus Therapeutics INC. | $17.86 | 2021 | |
| Medtronic, INC. | $17.76 | 2021 | |
| Merck Sharp & Dohme LLC | $16.57 | 2021 | |
| Ibsa Pharma INC. | $15.53 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $15.22 | 2021 | |
| Myriad Genetic Laboratories, INC. | $12.69 | 2023 | Mychoice Cdx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.